Early research (Phase 1)Study completedNCT00083070What this trial is testingTemozolomide in Treating Young Patients With Refractory or Recurrent LeukemiaWho this might be right forLeukemia Children's Oncology Group 16
Testing effectiveness (Phase 2)Study completedNCT00006225What this trial is testingPeripheral Stem Cell Transplantation in Treating Patients With Breast Cancer or Hematologic CancerWho this might be right forBreast CancerLeukemiaLymphoma+2 more Northwestern University
Large-scale testing (Phase 3)Study completedNCT01295710What this trial is testingStudy of US-ATG-F to Prevent Chronic Graft Versus Host Disease (GVHD)Who this might be right forGVHDAdult Acute Myeloid LeukemiaAdult Acute Lymphoid Leukemia+1 more Neovii Biotech 260
Large-scale testing (Phase 3)Study completedNCT00002868What this trial is testingInterferon-alfa With or Without Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Newly Diagnosed Chronic Myelogenous LeukemiaWho this might be right forLeukemia Eastern Cooperative Oncology Group 744
Testing effectiveness (Phase 2)Study completedNCT01413568What this trial is testingSafety and Efficacy of POL6326 for Mobilization/Transplant of Sibling Donor in Patients With Hematologic MalignanciesWho this might be right forAcute Myeloid Leukemia in RemissionAdult Acute Lymphoblastic Leukemia in RemissionChronic Myelogenous Leukemia (CML)+5 more Polyphor Ltd. 38
Not applicableEnded earlyNCT03955276What this trial is testingAn Open Label Navigational Investigation of Molecular Profile-Related Evidence Determining Individualized Cancer Therapy for Patients With Incurable Hematologic Malignancies (I-PREDICT Heme)Who this might be right forHematologic Cancer University of California, San Diego 13
Testing effectiveness (Phase 2)Study completedNCT00053248What this trial is testingArsenic Trioxide and Imatinib Mesylate in Treating Patients With Chronic Myelogenous LeukemiaWho this might be right forLeukemia OHSU Knight Cancer Institute 16
Testing effectiveness (Phase 2)Study completedNCT00052520What this trial is testingBiological Therapy in Treating Patients With Advanced Myelodysplastic Syndrome, Acute or Chronic Myeloid Leukemia, or Acute Lymphoblastic Leukemia Who Are Undergoing Stem Cell TransplantationWho this might be right forAdult Acute Myeloid Leukemia With 11q23 (MLL) AbnormalitiesAdult Acute Myeloid Leukemia With Inv(16)(p13;q22)Adult Acute Myeloid Leukemia With t(15;17)(q22;q12)+20 more Fred Hutchinson Cancer Center 37
Testing effectiveness (Phase 2)Study completedNCT03128359What this trial is testingHigh Dose Cyclophosphamide, Tacrolimus, and Mycophenolate Mofetil in Preventing Graft Versus Host Disease in Patients With Hematological Malignancies Undergoing Myeloablative or Reduced Intensity Donor Stem Cell TransplantWho this might be right forAcute LeukemiaChronic Lymphocytic Leukemia/Small Lymphocytic LymphomaChronic Myelogenous Leukemia, BCR-ABL1 Positive+12 more City of Hope Medical Center 38
Not applicableStudy completedNCT03045120What this trial is testingDetermining Change in Cardiovascular and Metabolic Risks in Patients With Chronic Phase Chronic Myeloid Leukemia Receiving BCR-ABL Tyrosine Kinase Inhibitor First-Line Therapy in the United StatesWho this might be right forChronic Phase Chronic Myeloid Leukemia Bristol-Myers Squibb 118
Not applicableStudy completedNCT05476562What this trial is testingStudy Conducted Among Patients With CMLWho this might be right forChronic Myeloid Leukemia Novartis Pharmaceuticals 3,234
Testing effectiveness (Phase 2)Study completedNCT02353728What this trial is testingStem Cell Monitoring for CML Patients Undergoing Nilotinib TherapyWho this might be right forChronic Myeloid Leukemia Weill Medical College of Cornell University 16
Testing effectiveness (Phase 2)Study completedNCT03672539What this trial is testingLiposome-encapsulated Daunorubicin-Cytarabine and Gemtuzumab Ozogamicin in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia (AML) or High Risk Myelodysplastic SyndromeWho this might be right forAcute Myeloid Leukemia Arising From Previous Myelodysplastic SyndromeChronic Myelomonocytic LeukemiaHigh Risk Myelodysplastic Syndrome+3 more M.D. Anderson Cancer Center 50
Large-scale testing (Phase 3)Ended earlyNCT01366612What this trial is testingFludarabine and Busulfan vs. Fludarabine, Busulfan and Total Body IrradiationWho this might be right forMyeloid MalignanciesAcute Myelogenous LeukemiaChronic Myelogenous Leukemia+2 more Hackensack Meridian Health 53
Testing effectiveness (Phase 2)Study completedNCT00003336What this trial is testingPilot Study Of Unrelated UCB Transplant for Non-Malignant Hematologic ConditionsWho this might be right forLeukemiaMyelodysplastic SyndromesMyelodysplastic/Myeloproliferative Diseases Case Comprehensive Cancer Center 6
Early research (Phase 1)Study completedNCT00005634What this trial is testingSuberoylanilide Hydroxamic Acid in Treating Patients With Advanced Solid Tumors That Have Not Responded to Previous TherapyWho this might be right forLeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm+3 more Memorial Sloan Kettering Cancer Center
Early research (Phase 1)Study completedNCT00114257What this trial is testingDecitabine and FR901228 in Treating Patients With Relapsed or Refractory Leukemia, Myelodysplastic Syndromes, or Myeloproliferative DisordersWho this might be right forChronic Myeloproliferative DisordersLeukemiaMyelodysplastic Syndromes+1 more National Cancer Institute (NCI) 36
Testing effectiveness (Phase 2)WithdrawnNCT01101412What this trial is testingAntimicrobial Solution or Saline Solution in Maintaining Catheter Patency and Preventing Catheter-Related Blood Infections in Patients With MalignanciesWho this might be right forChronic Myeloproliferative DisordersInfectionLeukemia+6 more M.D. Anderson Cancer Center
Testing effectiveness (Phase 2)Study completedNCT00534430What this trial is testingBusulfan, Etoposide, and Total-Body Irradiation in Treating Patients Undergoing Donor Stem Cell or Bone Marrow Transplant for Advanced Hematologic CancerWho this might be right forLeukemiaMyelodysplastic Syndromes City of Hope Medical Center 30
Testing effectiveness (Phase 2)Study completedNCT00004145What this trial is testingChemotherapy Plus Biological Therapy Followed By Peripheral Stem Cell Transplantation in Treating Patients With Hematologic CancerWho this might be right forLeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm+1 more University of Chicago 16